Medela Potentia Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Medela Potentia Tbk. trades at Rp210 (market cap 2.94T, 61.9K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 14.59M 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 6.2× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (14.59M versus 61.9K). Which is the better fit depends on your goals.
| MDLA | PRDL | |
|---|---|---|
Market Cap | 2.94T | 470.58B |
Volume | 61.9K | 14.59M |
Lot | 619 | 145.93K |
Turnover | 12.98M | 3.84B |
Average Price | 209.62 | 263.18 |
Value | 12.98M | 3.84B |
Indicative Equilibrium Price | 208 | 272 |
Indicative Equilibrium Volume | 18 | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.
Read more on MDLA →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →